Whole blood mRNA expression-based targets to discriminate active tuberculosis from latent infection and other pulmonary diseases.

Abstract

Current diagnostic tests for tuberculosis (TB) are not able to predict reactivation disease progression from latent TB infection (LTBI). The main barrier to predicting reactivation disease is the lack of our understanding of host biomarkers associated with progression from latent infection to active disease. Here, we applied an immune-based gene expression profile by NanoString platform to identify whole blood markers that can distinguish active TB from other lung diseases (OPD), and that could be further evaluated as a reactivation TB predictor. Among 23 candidate genes that differentiated patients with active TB from those with OPD, nine genes (CD274, CEACAM1, CR1, FCGR1A/B, IFITM1, IRAK3, LILRA6, MAPK14, PDCD1LG2) demonstrated sensitivity and specificity of 100%. Seven genes (C1QB, C2, CCR2, CCRL2, LILRB4, MAPK14, MSR1) distinguished TB from LTBI with sensitivity and specificity between 82 and 100%. This study identified single gene candidates that distinguished TB from OPD and LTBI with high sensitivity and specificity (both > 82%), which may be further evaluated as diagnostic for disease and as predictive markers for reactivation TB.

• Authors: Jéssica D Petrilli, Luana E Araújo, Luciane Sussuchi da Silva, Ana Carolina Laus, Igor Müller, Rui Manuel Reis, Eduardo Martins Netto, Lee W Riley, Sérgio Arruda, Adriano Queiroz
• Journal: Scientific reports (Sci Rep) Vol. 10 Issue 1 Pg. 22072 (12 16 2020) ISSN: 2045-2322 [Electronic] England
• PMID: 33328540 (Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)

Chemical References

• RNA, Messenger

Topics

• Adolescent
• Adult
• Female
• Gene Expression Regulation
• Humans
• Latent Tuberculosis (blood, diagnosis)
• Male
• Middle Aged
• Mycobacterium tuberculosis (metabolism)
• RNA, Messenger (blood)
• Tuberculosis, Pulmonary (blood, diagnosis)